Purchase order 4800225321

The University of Nebraska Medical Center, a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order (PO 4800225321) to MedChemExpress LLC on August 13, 2026. The award is valued at $90.00 and covers the procurement of one unit of Daraxonrasib (RMC-6236) 1MG, a pharmaceutical product identified by material number HY-148439. Delivery was scheduled for August 14, 2026, to UNMC General Supply at 601 South Saddle Creek Road, Omaha, Nebraska. The contracting organization is located in Nebraska, while the prime contractor, MedChemExpress LLC, is based in Monmouth Junction, New Jersey.

Payment terms for this transaction are Net 30, with freight prepaid to destination. The University of Nebraska's tax-exempt status (Tax Exempt #05-8905401) applies to the purchase, and payment will be processed through the Nebraska State Treasury. Per contract requirements, the vendor was obligated to acknowledge acceptance within 10 days of the order date, and all shipments were required to include packing slips with the purchase order number clearly marked. The expedited period of performance—spanning from August 13 through August 14, 2026—reflects the time-sensitive nature of this pharmaceutical procurement.